search

Active clinical trials for "Helicobacter Infections"

Results 171-174 of 174

Diagnosis Ability of Linked Color Imaging for Helicobacter Pylori Infection Compared With White...

Helicobacter Pylori Infection

There are lack of endoscopic criteria for diagnosing Helicobacter pylori (H. pylori) infection by conventional white light imaging (WLI). Linked color imaging (LCI) is a newly developed endoscopy technique, which can diagnose mucosal lesions and H. pylori infection by enhancing color contrast of the mucosa. The aim of the study is to investigate the ability of LCI for diagnosing H. pylori infection compared with WLI.

Unknown status8 enrollment criteria

Potential Adverse Developmental and Nutritional Consequences of Helicobacter Pylori Infection in...

Helicobacter Pylori InfectionIron Deficiency Anemia1 more

The investigators believe that there is an association between H. pylori infection and nutritional status and between H. pylori infection and cognitive development. The current study will examine this association in Israeli children, aged 6-12 years.

Unknown status5 enrollment criteria

Gamma-Glutamyl Transpeptidase (GGT): A Potential Diagnostic Marker for Helicobacter Pylori Infections...

HELICOBACTER PYLORI INFECTIONS

The investigators hypothesis: Presence of anti-GGT (antibody against GGT) indicates H. pylori infection.

Unknown status4 enrollment criteria

Endofaster Test for Helicobacter Pylori Detection in Patients on Proton Pump Inhibitor Therapy

Helicobacter Infections

H. pylori infection is the most important causative agent of gastritis, and subsequent atrophic gastritis. The endoscopic diagnosis of H. pylori infection relies on urease tests such as the Clo test. However, treatment with proton pump inhibitors (PPI) impairs the diagnostic yeld of urease tests. The EndoFaster test (NISO BioMed, Turin, Italy) is a new technology that has the advantage, over conventional urease tests, of a real-time analysis of the gastric juice that can provide information regarding Helicobacter pylori infection and pH value of the gastric contents. A well designed clinical study is therefore warranted to fully assess the performance of the EndoFaster test in detecting H. pylori infection in patients treated with PPI. We aim to perform a clinical study in an adult population in United Kingdom in order to determine the diagnostic accuracy of the Endo Faster test compared to the Clo test, histological diagnosis and the faecal antigen test in evaluating H.pylori infection. Patients on PPI will undergo a gastroscopy with multiple biopsies and during the exam NISO Biomed EndoFaster test, as well as the Clo test, will be carried out. H. pylori faecal antigen test will also be performed and used as gold standard. Diagnostic accuracy of the different methods will be determined.

Unknown status6 enrollment criteria
1...1718

Need Help? Contact our team!


We'll reach out to this number within 24 hrs